<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Neuropsychopharmacology</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuropsychopharmacology</journal-id>
<journal-title-group>
<journal-title>Neuropsychopharmacology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0893-133X</issn>
<issn pub-type="epub">1740-634X</issn>
<publisher>
<publisher-name>Nature Publishing Group</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27550733</article-id>
<article-id pub-id-type="pmc">5399236</article-id>
<article-id pub-id-type="pii">npp2016166</article-id>
<article-id pub-id-type="doi">10.1038/npp.2016.166</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Impact of Maternal Serotonin Transporter Genotype on Placental Serotonin, Fetal Forebrain Serotonin, and Neurodevelopment</article-title>
<alt-title alt-title-type="running">Maternal effects of SERT Ala56 variant</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Muller</surname>
<given-names>Christopher L</given-names>
</name>
<xref ref-type="aff" rid="aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anacker</surname>
<given-names>Allison MJ</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rogers</surname>
<given-names>Tiffany D</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Goeden</surname>
<given-names>Nick</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Keller</surname>
<given-names>Elizabeth H</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Forsberg</surname>
<given-names>C Gunnar</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kerr</surname>
<given-names>Travis M</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wender</surname>
<given-names>Carly LA</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Anderson</surname>
<given-names>George M</given-names>
</name>
<xref ref-type="aff" rid="aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stanwood</surname>
<given-names>Gregg D</given-names>
</name>
<xref ref-type="aff" rid="aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blakely</surname>
<given-names>Randy D</given-names>
</name>
<xref ref-type="aff" rid="aff3">3</xref>
<xref ref-type="aff" rid="aff7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bonnin</surname>
<given-names>Alexandre</given-names>
</name>
<xref ref-type="aff" rid="aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Veenstra-VanderWeele</surname>
<given-names>Jeremy</given-names>
</name>
<xref ref-type="aff" rid="aff2">2</xref>
<xref ref-type="aff" rid="aff8">8</xref>
<xref ref-type="aff" rid="aff9">9</xref>
<xref ref-type="aff" rid="aff10">10</xref>
<xref ref-type="corresp" rid="caf1">*</xref>
</contrib>
<aff id="aff1"><label>1</label><institution>Graduate Program in Neuroscience, Vanderbilt University</institution>, Nashville, TN, <country>USA</country></aff>
<aff id="aff2"><label>2</label><institution>Department of Psychiatry, Columbia University Medical School</institution>, New York, NY, <country>USA</country></aff>
<aff id="aff3"><label>3</label><institution>Department of Psychiatry, Vanderbilt University School of Medicine</institution>, Nashville, TN, <country>USA</country></aff>
<aff id="aff4"><label>4</label><institution>Department of Cell and Neurobiology and Zilkha Neurogenetic Institute, University of Southern California School of Medicine</institution>, Los Angeles, CA, <country>USA</country></aff>
<aff id="aff5"><label>5</label><institution>Child Study Center, Yale University School of Medicine</institution>, New Haven, CT, <country>USA</country></aff>
<aff id="aff6"><label>6</label><institution>Department of Biomedical Sciences, Florida State University</institution>, Tallahassee, FL, <country>USA</country></aff>
<aff id="aff7"><label>7</label><institution>Department of Pharmacology, Vanderbilt University School of Medicine</institution>, Nashville, TN, <country>USA</country></aff>
<aff id="aff8"><label>8</label><institution>New York State Psychiatric Institute</institution>, New York, NY, <country>USA</country></aff>
<aff id="aff9"><label>9</label><institution>Center for Autism and the Developing Brain, New York Presbyterian Hospital</institution>, New York, NY, <country>USA</country></aff>
<aff id="aff10"><label>10</label><institution>Sackler Institute for Developmental Psychobiology, Columbia University</institution>, New York, NY, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="caf1"><label>*</label><institution>Department of Psychiatry, Columbia University Medical School</institution>, 1051 Riverside Drive, Mail Unit 78, New York, NY 10032, <country>USA</country>, Tel: +646 774 5251, E-mail: <email>veenstr@nyspi.columbia.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<month>01</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epreprint">
<day>23</day>
<month>08</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>09</month>
<year>2016</year>
</pub-date>
<volume>42</volume>
<issue>2</issue>
<fpage>427</fpage>
<lpage>436</lpage>
<history>
<date date-type="received">
<day>07</day>
<month>05</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>16</day>
<month>07</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>04</day>
<month>08</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright Â© 2017 American College of Neuropsychopharmacology</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>American College of Neuropsychopharmacology</copyright-holder>
</permissions>
<abstract>
<p>Biomarker, neuroimaging, and genetic findings implicate the serotonin transporter (SERT) in autism spectrum disorder (ASD). Previously, we found that adult male mice expressing the autism-associated SERT Ala56 variant have altered central serotonin (5-HT) system function, as well as elevated peripheral blood 5-HT levels. Early in gestation, before midbrain 5-HT projections have reached the cortex, peripheral sources supply 5-HT to the forebrain, suggesting that altered maternal or placenta 5-HT system function could impact the developing embryo. We therefore used different combinations of maternal and embryo SERT Ala56 genotypes to examine effects on blood, placenta and embryo serotonin levels and neurodevelopment at embryonic day E14.5, when peripheral sources of 5-HT predominate, and E18.5, when midbrain 5-HT projections have reached the forebrain. Maternal SERT Ala56 genotype was associated with decreased placenta and embryonic forebrain 5-HT levels at E14.5. Low 5-HT in the placenta persisted, but forebrain levels normalized by E18.5. Maternal SERT Ala56 genotype effects on forebrain 5-HT levels were accompanied by a broadening of 5-HT-sensitive thalamocortical axon projections. In contrast, no effect of embryo genotype was seen in concepti from heterozygous dams. Blood 5-HT levels were dynamic across pregnancy and were increased in SERT Ala56 dams at E14.5. Placenta RNA sequencing data at E14.5 indicated substantial impact of maternal SERT Ala56 genotype, with alterations in immune and metabolic-related pathways. Collectively, these findings indicate that maternal SERT function impacts offspring placental 5-HT levels, forebrain 5-HT levels, and neurodevelopment.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>